Nalaganje...

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN

The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.

Shranjeno v:
Bibliografske podrobnosti
Glavni avtor: N. G. Gogolashvili
Format: Artigo
Jezik:Inglês
Izdano: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Serija:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Teme:
Online dostop:https://www.rpcardio.com/jour/article/view/192
Oznake: Označite
Brez oznak, prvi označite!